Aktie A14YE6 GLOBAL BLOOD THERAPEUTICS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Global Blood Therapeutics, Inc.

Aktien

A14YE6

US37890U1088

GBT

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Pfizer Completes $5.4 Billion Acquisition Of Sickle Cell Disease Drug Innovator
BioPharma Credit Receives $175 Million From Global Blood Therapeutics Investment
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P Global BMI Index
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P TMI Index
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P Biotechnology Select Industry Index
GLOBAL BLOOD THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Regi (form 8-K)
Global Blood Therapeutics, Inc. Announces Cessation of Ted W. Love as Chief Executive Officer
Global Blood Therapeutics, Inc. Announces Executive Changes
Pfizer : finalise l'acquisition de Global Blood Therapeutics
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from NASDAQ Composite Index
Pfizer Inc. completed the acquisition of Global Blood Therapeutics, Inc. from a group of shareholders.
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from NASDAQ Biotechnology Index
GLOBAL BLOOD THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
GLOBAL BLOOD THERAPEUTICS, INC. : Other Events (form 8-K)
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics Conference
Insider Sell: Global Blood Therapeutics
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
Insider Sell: Global Blood Therapeutics
Biotech stocks pin bounce back hopes on M&A boost
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14YE6 Aktie
  4. Nachrichten Global Blood Therapeutics, Inc.
  5. Andere Sprachen